G31.84

Mild cognitive impairment, so stated

Mild cognitive impairment (MCI) represents an intermediate clinical stage between the cognitive changes associated with normal biological aging and the more severe cognitive decline characteristic of dementia. It is characterized by measurable deficits in one or more cognitive domains—most commonly memory, executive function, attention, or visuospatial skills—that are noticeable to the patient or observers but do not yet significantly interfere with independent activities of daily living (ADLs). While individuals with MCI can generally perform complex tasks such as managing finances or driving, they may require more effort or compensatory strategies than previously. MCI is clinically significant as it often serves as a prodromal phase for neurodegenerative disorders, particularly Alzheimer's disease. The 'so stated' designation in ICD-10-CM implies that the clinician has explicitly diagnosed MCI based on clinical evaluation and, frequently, neuropsychological testing that confirms cognitive performance falls 1 to 1.5 standard deviations below the mean for the individual's age and education level.

Clinical Symptoms

  • Frequent forgetting of recent events or conversations
  • Difficulty performing multi-step tasks or complex sequences
  • Difficulty with word-finding or following the thread of a conversation
  • Reduced ability to maintain focus and attention on single tasks
  • Increased time required to complete familiar cognitive activities
  • Subtle changes in judgment or decision-making abilities
  • Mild disorientation in unfamiliar environments
  • Increased irritability, anxiety, or apathy related to cognitive performance
  • Subjective awareness of memory decline (subjective cognitive decline)
  • Misplacement of items more frequently than is normative for age

Common Causes

  • Early-stage Alzheimer's disease (amyloid-beta and tau protein accumulation)
  • Cerebrovascular disease, including chronic cerebral ischemia or microinfarcts
  • Lewy body pathology (alpha-synuclein deposition)
  • Frontotemporal lobar degeneration
  • Parkinson's disease-related neurodegeneration
  • Vascular risk factors including hypertension, diabetes, and hyperlipidemia
  • Metabolic or endocrine disturbances (e.g., Vitamin B12 deficiency, hypothyroidism)
  • Chronic neuroinflammation
  • Traumatic brain injury (TBI) history
  • Obstructive sleep apnea and chronic sleep fragmentation

Documentation & Coding Tips

Explicitly state the preservation of independence in basic activities of daily living to differentiate from dementia.

Example: Patient reports increasing difficulty with complex financial tasks but remains independent in dressing, bathing, and basic meal preparation. MoCA score of 24/30 confirms mild impairment in delayed recall and executive function. Diagnosis is mild cognitive impairment, so stated, rather than dementia. Billing focus: Functional status assessment. Risk adjustment: Distinguishes chronic G31.84 from acute or transient memory loss.

Billing Focus: Documentation must specify the lack of significant impact on daily independent living to support G31.84 over F03.90.

Document the use of validated objective screening tools and the specific scores obtained.

Example: Administered Montreal Cognitive Assessment (MoCA); patient scored 23 out of 30, with primary deficits in executive functioning and phonemic fluency. These objective findings correlate with patient's subjective memory complaints. Diagnosis: G31.84. Billing focus: Objective evidence of cognitive deficit. Risk adjustment: Supports medical necessity for cognitive assessment codes and long-term care planning.

Billing Focus: The presence of objective test scores justifies higher-level E/M complexity or specific neuropsychological testing codes.

Identify and document any known or suspected underlying etiology while maintaining the MCI clinical stage.

Example: Patient exhibits mild cognitive impairment, so stated, likely secondary to early-stage neurodegenerative process vs. small vessel ischemic disease. Neuroimaging shows mild hippocampal atrophy. Patient continues to manage medications and driving independently. Billing focus: Etiological specificity. Risk adjustment: Identifies the condition as a primary neurological disorder G31.84.

Billing Focus: Specifying underlying causes can help determine if F06.70 or G31.84 is the more accurate primary code.

Differentiate MCI from benign age-associated memory impairment or simple memory loss.

Example: Clinical evaluation reveals cognitive decline that is greater than expected for the patient's age and education level, but does not meet criteria for major neurocognitive disorder. Deficits noted in two domains (memory and visuospatial). Diagnosis: Mild cognitive impairment, so stated. Billing focus: Medical necessity for neurological referral. Risk adjustment: Moves the patient from a symptom-based code (R41.3) to a chronic condition code (G31.84).

Billing Focus: The term so stated in G31.84 requires an explicit clinical statement of the diagnosis to avoid coding as R41.3 (Memory loss).

Document the longitudinal history of cognitive decline provided by both the patient and an informant.

Example: Daughter reports a gradual 12-month decline in patient's ability to navigate new environments. Patient is aware of deficits but maintains a full social calendar. Physical exam reveals no focal deficits. Clinical diagnosis: G31.84. Billing focus: Use of collateral history. Risk adjustment: Demonstrates the chronic nature of the cognitive decline.

Billing Focus: Collateral information from family members supports the complexity of the MDM under the Data category of E/M coding.

Relevant CPT Codes

Related Diagnoses

Hierarchy